Noida Sector 12
Noida Sector 11
Faridabad
Preet Vihar, Delhi
Pandav Nagar, Delhi
Haridwar
Jaipur
Meerut
Rewari
Vadodara
Lung Cancer Treatment in Faridabad, Delhi, India
Overview
Metro Cancer Institute, Delhi, stands as one of the premier facilities for lung cancer treatment in Delhi, India. With state-of-the-art centers in Delhi (Saket, Patparganj, Shalimar Bagh), Ghaziabad (Vaishali), Mohali, and Bathinda, it offers comprehensive treatment options in surgical oncology, radiation oncology, and medical oncology. As one of the largest lung cancer hospital chains in India, Metro Cancer Institute ensures specialized care with dedicated daycare facilities, covering all major subspecialties and providing privacy for cancer patients.
With a team of over 100 oncologists, the institute is equipped to handle a wide range of oncological diseases, including lung cancer. The expert team comprises thoracic oncologists, pathologists, radiologists, radiation oncologists, pulmonologists, medical geneticists, genetic counselors, and other healthcare professionals. This multidisciplinary team collaborates to provide precise and personalized treatment plans, improving early detection and outcomes for lung cancer patients.
What is Lung Cancer?
Lung cancer involves the uncontrolled growth of abnormal cells in one or both lungs, impairing their function. As the most common cancer among Indian males, it often presents in advanced stages due to a low index of suspicion. Early detection and treatment are crucial for better outcomes.
Types of Lung Cancer
Lung cancer is classified into two main types based on biological behavior:
Causes of Lung Cancer
Lung cancer risk factors include:
Not everyone exposed to these risk factors develops lung cancer, but awareness and preventive measures are important.
Lung Cancer Symptoms
Lung cancer symptoms can be vague and similar to other conditions. Common symptoms include:
Additional symptoms may arise from cancer spreading to other parts of the body. Persistent symptoms lasting more than four weeks should prompt medical evaluation.
Diagnosis of Lung Cancer
Diagnosis involves a thorough medical history, physical examination & various tests, including:
These tests help determine the presence, location, and extent of cancer, aiding in staging and treatment planning.
Approach to Treating Lung Cancer
Tumor Board
At Metro Cancer Institute, Delhi, a multidisciplinary team approach is employed for lung cancer treatment. The Disease Management Group (DMG) Tumor Board, consisting of specialists from various fields, collaborates to develop personalized treatment plans for each patient. The board includes experts from thoracic surgical oncology, radiation oncology, medical oncology, pathology, imaging, and related disciplines, ensuring comprehensive and customized care.
The institute is dedicated to offering advanced and individualized lung cancer treatment, leveraging the collective expertise of its specialized team to achieve the best possible outcomes for patients.
Expertise in Treating Lung Cancer
Comprehensive Care at Metro Cancer Institute, Delhi
Metro Cancer Institute, Delhi, is a leading facility for lung cancer treatment in India. The institute provides state-of-the-art services for early diagnosis, staging, treatment, and hospital-based care. The Disease Management Group (DMG) for lung cancer at Metro Cancer Institute is a specialized unit where clinicians focus exclusively on lung cancer, developing world-class expertise in the field. Weekly meetings are held to discuss patient cases and devise optimal treatment plans. These meetings are attended by a multidisciplinary team, including surgeons, radiation and medical oncologists, pathologists, molecular oncologists, and radiologists, ensuring a comprehensive approach to patient care.
Key Features of Our Lung Cancer Care:
Lung Cancer Treatments at Metro Hospitals in Delhi, India
Metro Cancer Institute is equipped with cutting-edge technology and a team of oncology experts, offering holistic care for lung cancer patients. The primary treatments include surgery, radiotherapy, chemotherapy, and chemo-immunotherapy. The choice of treatment depends on the type and stage of lung cancer, lung function, overall health, and patient preferences.
Surgical Options
Lung cancer surgery is recommended when cancer is localized, and the patient’s overall health and lung function are adequate.
Chemotherapy
Chemotherapy uses anti-cancer drugs to destroy cancer cells. It is particularly effective in treating small-cell carcinoma and can be used as an adjunctive treatment in non-small cell carcinoma to increase the likelihood of cure or to shrink tumors before surgery.
Radiation Therapy
Radiation therapy involves high-energy beams to target and kill cancer cells. Advanced techniques like Intensity-Modulated Radiotherapy (IMRT) and Image-Guided Radiotherapy (IGRT) allow for precise targeting, minimizing damage to healthy tissue. Gated Radiation Therapy synchronizes treatment with the patient’s breathing cycle for greater accuracy.
Targeted Therapy/Immunotherapy
Targeted therapy and immunotherapy involve drugs designed to attack specific genetic changes in cancer cells. These treatments are particularly effective for non-smokers or patients with specific genetic mutations. They can be administered orally or intravenously, offering a less invasive option compared to traditional therapies.
Holistic Cancer Care Approach
At Metro Cancer Institute, we emphasize a personalized treatment plan for each patient. Our Tumor Board, consisting of specialists from various disciplines, collaborates to provide a customized approach, ensuring the best possible care for lung cancer patients. This comprehensive care model is supported by the latest technology and a dedicated team of experts committed to achieving the best patient outcomes.
Top of Form
Bottom of Form
FAQs About Lung Cancer
1. What are the different treatment options available for lung cancer?
Lung cancer treatment options include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. The choice of treatment depends on the cancer type, stage, and patient’s health.
2. How is the stage of lung cancer determined?
The stage of lung cancer is determined through a combination of imaging tests like CT and PET scans and biopsies. These tests assess the size, location, and spread of the tumour, including whether it has metastasised to other body parts.
3. How does surgery contribute to the treatment of lung cancer?
Surgery is often a primary treatment for early-stage lung cancer, involving the removal of the tumour and possibly nearby lymph nodes. Depending on the tumour’s location and size, procedures like lobectomy, pneumonectomy, or segmentectomy may be performed.
4. Can radiation therapy be used to treat lung cancer?
Yes, radiation therapy uses high-energy beams to target and kill cancer cells. It can be a primary treatment, an adjunct to surgery or chemotherapy, or a palliative measure to relieve symptoms in advanced cancer stages.
5. What are the benefits and risks of chemotherapy in lung cancer treatment?
Chemotherapy uses drugs to destroy cancer cells and may be used before surgery to shrink tumours, after surgery to eliminate residual cells, or in advanced stages. While effective, it can cause side effects such as nausea, hair loss, and reduced blood cell counts.
6. Is targeted therapy a viable treatment option for lung cancer?
Targeted therapy is effective for certain lung cancers, especially those with specific genetic mutations. These drugs specifically target cancer cell abnormalities, often resulting in fewer side effects than traditional chemotherapy.
7. Can immunotherapy be an effective treatment option for lung cancer?
Yes, immunotherapy can treat lung cancer by boosting the body’s immune system to recognize and destroy cancer cells. It’s particularly useful in certain advanced or metastatic lung cancer cases.
8. What is the role of palliative care in lung cancer treatment?
Palliative care focuses on providing relief from symptoms, pain, and stress caused by lung cancer. It aims to improve the quality of life for patients and their families, regardless of the disease stage.
9. How is the treatment plan for lung cancer determined?
A lung cancer treatment plan is based on the cancer’s type and stage, the patient’s overall health, and their preferences. A multidisciplinary team of specialists collaborates to create a personalized plan.
10. Can lung cancer be treated with a combination of therapies?
Yes, lung cancer is often treated with a combination of therapies, including surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. This multimodal approach can be tailored to the specific needs of the patient.
11. Are there any clinical trials available for lung cancer treatment?
Clinical trials for lung cancer treatment are ongoing, offering patients access to new and potentially more effective therapies. Participation can provide cutting-edge treatment options and contribute to advancing medical knowledge.
12. Can lung cancer be treated with minimally invasive procedures?
Minimally invasive procedures, such as video-assisted thoracic surgery (VATS) and robotic-assisted surgery, are available for lung cancer treatment. These methods result in smaller incisions, less trauma, faster recovery, and shorter hospital stays compared to traditional surgery.
13. What is the prognosis for lung cancer patients?
The prognosis for lung cancer patients depends on the cancer type, stage, overall health, and response to treatment. Early detection and advanced treatments can improve outcomes, but the prognosis can vary significantly.
14. Does the type of lung cancer affect the treatment approach?
Yes, treatment strategies differ for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) due to their distinct characteristics. The type of lung cancer influences the choice of surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy.
15. Can lung cancer be treated without surgery?
Yes, lung cancer can be treated without surgery, especially if the tumour is inoperable or the patient is not a suitable candidate for surgery. Alternative treatments include chemotherapy, radiation therapy, targeted therapy, and immunotherapy.
Top of Form
Bottom of Form
16. What are the side effects of different lung cancer treatments?
The side effects of lung cancer treatments vary based on the specific treatment. Surgery may lead to pain, risk of infection, and complications related to anesthesia. Radiation therapy can cause fatigue, skin irritation, and lung inflammation. Chemotherapy often results in hair loss, nausea, vomiting, and a decrease in blood cell counts. Targeted therapies may have specific side effects depending on the drugs used, including rashes and diarrhea. Immunotherapy can cause immune-related side effects, such as inflammation in various organs. Each patient’s experience can differ, and side effects can range from mild to severe.
17. How does smoking cessation affect lung cancer treatment?
Quitting smoking is crucial for lung cancer patients as it can significantly improve treatment outcomes and overall health. Continued smoking can reduce the effectiveness of treatments, increase the risk of complications, and worsen the prognosis. Stopping smoking helps prevent further lung damage, enhances the body’s ability to heal, and improves overall quality of life.
18. Can lung cancer treatment affect fertility?
Yes, some lung cancer treatments, particularly certain chemotherapy drugs and radiation therapy to the pelvic area, can affect fertility. Patients concerned about fertility should discuss this with their healthcare team before starting treatment. Fertility preservation options, such as sperm banking or egg freezing, may be available and can be discussed with a fertility specialist.
19. Is there a role for nutrition and exercise in lung cancer treatment?
Nutrition and exercise play a vital role in supporting patients during lung cancer treatment. A balanced diet can help maintain energy levels, support the immune system, and manage treatment side effects. Regular physical activity, as tolerated, can improve strength, reduce fatigue, and enhance overall well-being. Patients should consult their healthcare team for personalized recommendations based on their treatment plan and physical condition.
20. Can lung cancer treatment be personalized based on genetic testing?
Yes, genetic testing can help personalize lung cancer treatment by identifying specific genetic mutations or alterations in cancer cells. This information allows doctors to select targeted therapies that are most effective for the patient’s unique genetic profile, improving treatment outcomes and minimizing unnecessary side effects.
21. What supportive care options are available during lung cancer treatment?
Supportive care options are available to manage symptoms, alleviate side effects, and improve the quality of life during lung cancer treatment. These may include pain management, nutritional support, psychological counseling, integrative therapies such as acupuncture or massage, and palliative care services. Supportive care focuses on enhancing comfort and well-being throughout the treatment process.
22. Can lung cancer treatments impact the heart or other organs?
Certain lung cancer treatments, such as radiation therapy or specific chemotherapy drugs, can impact the heart or other organs. For example, radiation therapy may increase the risk of heart disease, while some chemotherapy agents can cause cardiac toxicity or damage to the kidneys or liver. Healthcare providers monitor patients closely and take preventive measures to minimize these risks.
23. Can lung cancer treatment cause hair loss?
Hair loss is a common side effect of some chemotherapy drugs used in lung cancer treatment. However, not all chemotherapy regimens cause hair loss, and the extent of hair loss can vary. Radiation therapy generally causes hair loss only in the treated area. Hair loss can be distressing, but it is usually temporary, with hair regrowth occurring after treatment ends.
24. What are the key treatment considerations for elderly patients with lung cancer?
Elderly patients with lung cancer require special consideration due to age-related factors, such as comorbidities, frailty, and tolerance to treatments. Treatment plans for elderly patients are often individualized, balancing the potential benefits and risks of aggressive therapies. In some cases, less intensive treatments or supportive care may be prioritized to maintain the patient’s quality of life.
25. Can lung cancer treatment cause lung damage or breathing difficulties?
Lung cancer treatments, particularly radiation therapy and certain surgeries, can sometimes lead to lung damage or breathing difficulties. These risks are carefully weighed against the benefits of treatment. Radiation therapy can cause lung inflammation, fibrosis, or pneumonitis, while surgery may reduce lung capacity. Patients are monitored closely, and interventions are implemented as needed to manage complications and support respiratory function.
26. Is there a difference in the treatment approach for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)?
Yes, the treatment approaches for NSCLC and SCLC differ significantly. NSCLC, which is more common, is typically treated with surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy, depending on the stage and specific characteristics of the cancer. SCLC, known for its rapid growth and spread, is often treated with chemotherapy and radiation therapy. Immunotherapy may also be used for SCLC, particularly in extensive-stage disease. Surgery is less common in SCLC due to its aggressive nature and tendency to spread early.
27. How might lung cancer treatments affect the immune system?
Yes, lung cancer treatments such as chemotherapy and immunotherapy can impact the immune system. Chemotherapy can reduce the number of immune cells, increasing the risk of infections. Immunotherapy, designed to enhance the immune system’s ability to fight cancer, can also cause immune-related side effects by overstimulating the immune system. These effects require careful monitoring and management by healthcare professionals.
28. Are there any long-term effects of lung cancer treatment?
Long-term effects of lung cancer treatment can vary based on the type and extent of treatment. These may include lung damage, such as fibrosis or reduced lung function, cardiovascular issues, secondary cancers, and hormonal imbalances. Patients may also experience chronic pain, fatigue, or cognitive changes. Regular follow-up care is crucial to monitor for and manage any long-term effects, helping to maintain the best possible quality of life.
29. Is it possible for lung cancer treatment to be effective in advanced stages of the disease?
Yes, lung cancer treatment can still be effective in advanced stages. While the primary goal may shift from curing the disease to controlling it and improving the quality of life, treatments like targeted therapy, immunotherapy, and chemotherapy can help manage symptoms, slow disease progression, and potentially extend survival. The choice of treatment depends on factors such as the specific type of lung cancer, genetic mutations, and the patient’s overall health.
30. What are the options for pain management during lung cancer treatment?
Pain management for lung cancer patients includes a range of options, tailored to the individual’s needs. Medications such as opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and corticosteroids can help manage pain. Non-pharmacological approaches, such as acupuncture, physical therapy, nerve blocks, and relaxation techniques, can also be effective. A multidisciplinary team typically manages pain control, ensuring comprehensive care.
31. Can lung cancer treatment affect a patient’s mental health?
Lung cancer treatment can significantly impact a patient’s mental health. The diagnosis and treatment process can lead to emotional distress, anxiety & depression. Supportive care, including psychological counseling, support groups, and sometimes medication, can be beneficial. Integrative therapies like mindfulness and relaxation exercises can also help patients cope with the emotional challenges of cancer treatment.
32. Can lung cancer treatment be challenging in patients with pre-existing lung conditions like COPD or asthma?
Yes, treating lung cancer in patients with pre-existing lung conditions like chronic obstructive pulmonary disease (COPD) or asthma can be challenging. These conditions can complicate the management of lung cancer, as they may limit treatment options and increase the risk of complications. Treatment plans must be carefully tailored to balance cancer control with the patient’s respiratory health, often requiring close monitoring and a multidisciplinary approach.
33. Are there different treatment considerations for lung cancer patients with autoimmune disorders, such as rheumatoid arthritis or lupus?
Lung cancer patients with autoimmune disorders like rheumatoid arthritis or lupus require special consideration. Some cancer treatments, particularly immunotherapy, can exacerbate autoimmune symptoms by boosting the immune system. In such cases, close coordination between oncologists and rheumatologists is necessary to manage both the cancer and the autoimmune condition safely. The treatment plan may involve balancing the efficacy of cancer therapies with the management of autoimmune disease activity.
34. Are there specific treatment options available for lung cancer patients with a history of smoking-related lung diseases, such as emphysema or bronchitis?
Patients with a history of smoking-related lung diseases, such as emphysema or bronchitis, require specialized treatment approaches. These conditions can compromise lung function, making it crucial to select treatments that minimize further lung damage. Minimally invasive surgical techniques, targeted therapies, and carefully planned radiation therapy may be preferred. Quitting smoking is vital for improving treatment outcomes and lung health.
35. What are the treatment considerations for lung cancer patients with compromised kidney or liver function?
Lung cancer patients with compromised kidney or liver function need careful treatment planning. These organs play a crucial role in metabolizing many chemotherapy drugs and other medications. Dose adjustments and alternative treatments may be necessary to prevent toxicity. Regular monitoring of kidney and liver function is essential to ensure safe and effective treatment.
36. What are treatment considerations for lung cancer patients with compromised immune systems, such as those undergoing organ transplantation or with HIV/AIDS?
Patients with compromised immune systems, such as those who have undergone organ transplantation or have HIV/AIDS, require careful consideration in lung cancer treatment. These patients are at higher risk for infections and complications from treatments like immunotherapy, which can overstimulate the immune system. A personalized treatment approach, often avoiding immunotherapy, is necessary to balance cancer treatment with the risk of complications. Close collaboration between oncologists and other specialists is essential for optimal care.
Reviewed by Dr. R.K. Choudhary, Director & Head – Medical Oncology, Haemato Oncology & BMT, on 8 Aug 2024.
